REGULUS THERAPEUTICS

Company Profile for Regulus Therapeutics

Regulus Therapeutics is a biopharmaceutical company.

It is a manufacturer.

Regulus Therapeutics is a clinical-stage biopharmaceutical company dedicated to the discovery and development of innovative RNA-targeted therapeutics. Based in the United States, the company focuses on advancing new medicines for diseases with unmet medical needs. Their operations involve extensive research and development activities, including drug discovery, preclinical testing, clinical trials, and ultimately, the production or oversight of the production of their proprietary drug candidates. Therefore, it operates as a developer and manufacturer of pharmaceutical products, not a trader of existing goods. There is no publicly available information indicating a separate entity operating as "Regulus Therapeutics India" functioning as a factory or trading company.

Regulus Therapeutics Corp. focuses on discovering and developing microRNA (miRNA) therapeutics. Their pipeline includes:

* RGLS4326: For autosomal dominant polycystic kidney disease (ADPKD)

* RGLS8429: Also for ADPKD.

* Several pre-clinical programs targeting oncology and immunology indications.

Note: This information is based on publicly available data and may not reflect the most current product lineup.